Literature DB >> 25502596

1,10-phenanthroline inhibits the metallopeptidase secreted by Phialophora verrucosa and modulates its growth, morphology and differentiation.

Marcela Queiroz Granato1, Priscila de Araújo Massapust, Sonia Rozental, Celuta Sales Alviano, André Luis Souza dos Santos, Lucimar Ferreira Kneipp.   

Abstract

Phialophora verrucosa is one of the etiologic agents of chromoblastomycosis, a fungal infection that affects cutaneous and subcutaneous tissues. This disease is chronic, recurrent and difficult to treat. Several studies have shown that secreted peptidases by fungi are associated with important pathophysiological processes. Herein, we have identified and partially characterized the peptidase activity secreted by P. verrucosa conidial cells. Using human serum albumin as substrate, the best hydrolysis profile was detected at extreme acidic pH (3.0) and at 37 °C. The enzymatic activity was completely blocked by classical metallopeptidase inhibitors/chelating agents as 1,10-phenanthroline and EGTA. Zinc ions stimulated the metallo-type peptidase activity in a dose-dependent manner. Several proteinaceous substrates were cleaved, in different extension, by the P. verrucosa metallopeptidase activity, including immunoglobulin G, fibrinogen, collagen types I and IV, fibronectin, laminin and keratin; however, mucin and hemoglobin were not susceptible to proteolysis. As metallopeptidases participate in different cellular metabolic pathways in fungal cells, we also tested the influence of 1,10-phenanthroline and EGTA on P. verrucosa development. Contrarily to EGTA, 1,10-phenanthroline inhibited the fungal viability (MIC 0.8 µg/ml), showing fungistatic effect, and induced profound morphological alterations as visualized by transmission electron microscopy. In addition, 1,10-phenanthroline arrested the filamentation process in P. verrucosa. Our results corroborate the supposition that metallopeptidase inhibitors/chelating agents have potential to control crucial biological events in fungal agents of chromoblastomycosis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25502596     DOI: 10.1007/s11046-014-9832-7

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  39 in total

Review 1.  Co-catalytic metallopeptidases as pharmaceutical targets.

Authors:  Richard C Holz; Krzysztof P Bzymek; Sabina I Swierczek
Journal:  Curr Opin Chem Biol       Date:  2003-04       Impact factor: 8.822

2.  Identification of a metallopeptidase with TOP-like activity in Paracoccidioides brasiliensis, with increased expression in a virulent strain.

Authors:  Ellen T Gravi; Thaysa Paschoalin; Bianca R Dias; Dayson F Moreira; José E Belizario; Vitor Oliveira; Adriana K Carmona; Maria A Juliano; Luiz R Travassos; Elaine G Rodrigues
Journal:  Med Mycol       Date:  2011-07-05       Impact factor: 4.076

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 4.  Managing chromoblastomycosis.

Authors:  Mahreen Ameen
Journal:  Trop Doct       Date:  2010-04       Impact factor: 0.731

5.  Surface phosphatase in Rhinocladiella aquaspersa: biochemical properties and its involvement with adhesion.

Authors:  Lucimar F Kneipp; Andressa S Magalhães; Erika A Abi-Chacra; Lucieri O P Souza; Celuta S Alviano; André L S Santos; José R Meyer-Fernandes
Journal:  Med Mycol       Date:  2012-02-09       Impact factor: 4.076

6.  Metallopeptidase inhibitors arrest vital biological processes in the fungal pathogen Scedosporium apiospermum.

Authors:  Bianca A Silva; Ana Luíza Souza-Gonçalves; Marcia R Pinto; Eliana Barreto-Bergter; André L S Santos
Journal:  Mycoses       Date:  2011-03       Impact factor: 4.377

7.  Pseudallescheria boydii releases metallopeptidases capable of cleaving several proteinaceous compounds.

Authors:  Bianca A Silva; Marcia R Pinto; Rosangela M A Soares; Eliana Barreto-Bergter; André L S Santos
Journal:  Res Microbiol       Date:  2006-01-20       Impact factor: 3.992

Review 8.  Biology and pathogenesis of Fonsecaea pedrosoi, the major etiologic agent of chromoblastomycosis.

Authors:  André L S Santos; Vanila F Palmeira; Sonia Rozental; Lucimar F Kneipp; Leonardo Nimrichter; Daniela S Alviano; Marcio L Rodrigues; Celuta S Alviano
Journal:  FEMS Microbiol Rev       Date:  2007-07-23       Impact factor: 16.408

9.  In vitro activity of antifungal drugs against Cladophialophora species associated with human chromoblastomycosis.

Authors:  R G Vitale; M Perez-Blanco; G S De Hoog
Journal:  Med Mycol       Date:  2009-02       Impact factor: 4.076

10.  Insights into the mode of action of the anti-Candida activity of 1,10-phenanthroline and its metal chelates.

Authors:  M McCann; M Geraghty; M Devereux; D O'Shea; J Mason; L O'Sullivan
Journal:  Met Based Drugs       Date:  2000
View more
  8 in total

1.  Administration of Zinc Chelators Improves Survival of Mice Infected with Aspergillus fumigatus both in Monotherapy and in Combination with Caspofungin.

Authors:  Paris Laskaris; Ahmad Atrouni; José Antonio Calera; Christophe d'Enfert; Hélène Munier-Lehmann; Jean-Marc Cavaillon; Jean-Paul Latgé; Oumaïma Ibrahim-Granet
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

Review 2.  Chromoblastomycosis.

Authors:  Flavio Queiroz-Telles; Sybren de Hoog; Daniel Wagner C L Santos; Claudio Guedes Salgado; Vania Aparecida Vicente; Alexandro Bonifaz; Emmanuel Roilides; Liyan Xi; Conceição de Maria Pedrozo E Silva Azevedo; Moises Batista da Silva; Zoe Dorothea Pana; Arnaldo Lopes Colombo; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

3.  Dual Mechanism of Action of 5-Nitro-1,10-Phenanthroline against Mycobacterium tuberculosis.

Authors:  Saqib Kidwai; Chan-Yong Park; Shradha Mawatwal; Prabhakar Tiwari; Myung Geun Jung; Tannu Priya Gosain; Pradeep Kumar; David Alland; Sandeep Kumar; Avinash Bajaj; Yun-Kyung Hwang; Chang Sik Song; Rohan Dhiman; Ill Young Lee; Ramandeep Singh
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

4.  1,10-Phenanthroline-5,6-Dione-Based Compounds Are Effective in Disturbing Crucial Physiological Events of Phialophora verrucosa.

Authors:  Marcela Queiroz Granato; Diego de Souza Gonçalves; Sergio Henrique Seabra; Malachy McCann; Michael Devereux; André Luis Souza Dos Santos; Lucimar Ferreira Kneipp
Journal:  Front Microbiol       Date:  2017-01-30       Impact factor: 5.640

5.  Aspartic peptidase of Phialophora verrucosa as target of HIV peptidase inhibitors: blockage of its enzymatic activity and interference with fungal growth and macrophage interaction.

Authors:  Marcela Q Granato; Ingrid S Sousa; Thabatta L S A Rosa; Diego S Gonçalves; Sergio H Seabra; Daniela S Alviano; Maria C V Pessolani; André L S Santos; Lucimar F Kneipp
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

6.  Biofilm Formation by Chromoblastomycosis Fungi Fonsecaea pedrosoi and Phialophora verrucosa: Involvement with Antifungal Resistance.

Authors:  Ingrid S Sousa; Thaís P Mello; Elaine P Pereira; Marcela Q Granato; Celuta S Alviano; André L S Santos; Lucimar F Kneipp
Journal:  J Fungi (Basel)       Date:  2022-09-15

7.  Fonsecaea pedrosoi Sclerotic Cells: Secretion of Aspartic-Type Peptidase and Susceptibility to Peptidase Inhibitors.

Authors:  Vanila F Palmeira; Fatima R V Goulart; Marcela Q Granato; Daniela S Alviano; Celuta S Alviano; Lucimar F Kneipp; André L S Santos
Journal:  Front Microbiol       Date:  2018-06-29       Impact factor: 5.640

8.  Photodynamic therapy combined with antifungal drugs against chromoblastomycosis and the effect of ALA-PDT on Fonsecaea in vitro.

Authors:  Yongxuan Hu; Xinyu Qi; Hengbiao Sun; Yan Lu; Yanqing Hu; Xuyang Chen; Kangxing Liu; Yemei Yang; Zuhao Mao; Zhong Wu; Xianyi Zhou
Journal:  PLoS Negl Trop Dis       Date:  2019-10-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.